Colambda NCRE Stock
Colambda Price Chart
Colambda NCRE Financial and Trading Overview
| Colambda stock price | 0.0003 USD |
| Previous Close | 1 USD |
| Open | 0.1 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1 - 1 USD |
| 52 Week Range | 0.06 - 2.1 USD |
| Volume | 3.77K USD |
| Avg. Volume | 194 USD |
| Market Cap | 79.15M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.003 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NCRE Valuation Measures
| Enterprise Value | 79.55M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.845238 |
| Price/Book (mrq) | 200 |
| Enterprise Value/Revenue | 5.875 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Colambda Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 33.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.1 USD |
| 52 Week Low | 0.06 USD |
| 50-Day Moving Average | 1 USD |
| 200-Day Moving Average | 1.01 USD |
NCRE Share Statistics
| Avg. Volume (3 month) | 194 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 12.48M |
| Float | 33.64M |
| Short Ratio | N/A |
| % Held by Insiders | 13.20% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -3.52% |
| Operating Margin (ttm) | -2.70% |
| Gross Margin | 11.35% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 13.54M USD |
| Revenue Per Share (ttm) | 0.19 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -477673 USD |
| Diluted EPS (ttm) | -0.003 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 188.97K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 585.42K USD |
| Total Debt/Equity (mrq) | 90.03 USD |
| Current Ratio (mrq) | 1.516 |
| Book Value Per Share (mrq) | 0.005 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1168486 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Colambda
| Country | United States |
| State | AZ |
| City | Tucson |
| Address | 1870 West Prince Road |
| ZIP | 85705 |
| Phone | 281-928-4425 |
| Website | https://www.colambdatechnologies.com |
| Industry | Auto Parts |
| Sector(s) | Consumer Cyclical |
| Full Time Employees | 301 |
Colambda Technologies, Inc. operates as a research and development company in the alternative energy sector. It intends to develop the Emissions Zero Module, a product that connects to a vehicle battery to create a concentrated charge to the ignition system to enable a more complete burn and reduce carbon emissions. The company was incorporated in 1979 and is based in Tucson, Arizona.
Q&A For Colambda Stock
What is a current NCRE stock price?
Colambda NCRE stock price today per share is 0.0003 USD.
How to purchase Colambda stock?
You can buy NCRE shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Colambda?
The stock symbol or ticker of Colambda is NCRE.
Which industry does the Colambda company belong to?
The Colambda industry is Auto Parts.
How many shares does Colambda have in circulation?
The max supply of Colambda shares is 79.15M.
What is Colambda Price to Earnings Ratio (PE Ratio)?
Colambda PE Ratio is now.
What was Colambda earnings per share over the trailing 12 months (TTM)?
Colambda EPS is -0.003 USD over the trailing 12 months.
Which sector does the Colambda company belong to?
The Colambda sector is Consumer Cyclical.